Kamada’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Kamada is a biopharmaceutical company that develops and commercializes protein-based therapeutics for the treatment of orphan disease. Read more

Amir London's photo - CEO of Kamada

CEO

Amir London

CEO Approval Rating

90/100

Founded:

1990

Status:

PublicNASDAQKMDA

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Grifols is perceived as one of Kamada's biggest rivals. Grifols was founded in 1940, and its headquarters is in Barcelona, Barcelona. Grifols competes in the Health Care Equipment field. Grifols has 23,681 more employees than Kamada.

CSL is one of Kamada's top rivals. CSL is a Private company that was founded in 1904 in King of Prussia, Pennsylvania. Like Kamada, CSL also works within the Pharmaceuticals field. Compared to Kamada, CSL has 24,681 more employees.

Takeda is Kamada's #3 rival. Takeda is a Public company that was founded in Tokyo, Tōkyō Prefecture in 1781. Like Kamada, Takeda also competes in the Pharmaceuticals sector. Takeda has 49,259 more employees vs. Kamada.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Apple a competitor of Kamada?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$128.4M

Kamada's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 10.7B. Over the last three quarters, Kamada's revenue has grown by 0.7%. Specifically, in Q1 2020's revenue was $33.3M; in Q4 2019, it was $16.9M; in Q3 2019, it was $33.1M.

Acquisitions

No recent acquisitions found related to Kamada

Kamada Funding History

$25M

Since Kamada was founded in 1990, it has participated in 1 round of funding. In total Kamada has raised $25.0M. Kamada's funding round was on Jan 2020 for a total of $25.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Jan 2020
$25M

FIMI Opportunity Fund

Total Funding: $25M

Since Kamada was founded in 1990, it has participated in 1 round of funding. In total Kamada has raised $25.0M. Kamada's funding round was on Jan 2020 for a total of $25.0M

Investments

No recent investments found related to Kamada

Kamada News

August 25, 2020FinanzNachrichten

Leading Biotech Companies Kedrion Biopharma of Italy and Kamada Ltd. of Israel Continue Their Collaboration to Develop a New Anti-COVID Plasma-Based Treatment

CASTELVECCHIO PASCOLI, Italy, Aug. 25, 2020 /PRNewswire/ -- Two innovative bio-pharma companies speci... See more »
August 12, 2020BioSpace

Kamada Reports Second Quarter and First Six Months of 2020 Financial Results, Recent Corporate Achievements and Strong Cash Position

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announce... See more »
August 5, 2020Benzinga

Kamada to Announce Second Quarter Ended June 30, 2020 Financial Results and Host Conference Call on August 12, 2020

REHOVOT, Israel, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived ... See more »
June 21, 2020NoCamels

Israeli Biopharma Company Kamada To Roll Out Antibody Treatment For COVID-19

The Rehovot-based firm said it completed the manufacturing of the first batch of its plasma-derived I... See more »
June 17, 2020CTech

Israeli company Kamada to offer antibody treatment to Covid-19 patients

ג€�To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a ... See more »
June 17, 2020firstwordpharma

Kamada Announces Availability of its Plasma-Derived Hyperimmune IgG Therapy for Coronavirus Disease (COVID-19) for Compassionate Use Treatment in Israel

Kamada Completed Manufacturing and Released the First Batch of its Plasma-Derived Immunoglobulin Prod... See more »

Kamada Press Releases

February 27, 2019GlobeNewswire

Kamada Files Annual Report for the Year Ended December 31, 2018

REHOVOT, Israel, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derive... See more »
January 2, 2019GlobeNewswire

Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018

Full-Year 2018 Revenue Expected to be Between $113 Million and $115 Million... See more »
September 25, 2018GlobeNewswire

Kamada to Present Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference

REHOVOT, Israel, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-der... See more »
July 10, 2018GlobeNewswire

Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

Company Plans to Submit Clinical Trial Application and Intends to Engage in Discussions for Strategic... See more »
April 24, 2018Marketwired

Tetra Bio-Pharma Signs Landmark Commercialization Term Sheet for its Lead Pharmaceutical Product, PPP001, in Israel

OTTAWA, ONTARIO--(Marketwired - April 24, 2018) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (T... See more »
April 23, 2018GlobalNewswire

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:K... See more »

Kamada Videos

August 13, 2019Kamada Youtube Channel

"Kamada Facility Footage" on YOUTUBE

June 3, 2017Kamada Youtube Channel

"Kamada Overview 2017" on YOUTUBE

April 7, 2016Kamada Youtube Channel

"NASDAQ opening bell" on YOUTUBE

April 7, 2016Kamada Youtube Channel

"Kamada Milestone Movie 6/2013" on YOUTUBE

December 3, 2015Kamada Youtube Channel

"FOSTER extrafine in COPD" on YOUTUBE

Headquarters

2 Holzman St, Science Park, P.O Box 4081

Rehovot, Tel Aviv District7670402

972-8-9406472

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Kamada is a biopharmaceutical company that develops and commercializes protein-based therapeutics for the treatment of orphan disease. Kamada was founded in 1990. Kamada's headquarters is located in Rehovot, Tel Aviv District, IL 7670402. It has raise...

CEO

Kamada's CEO, Amir London, currently has an approval rating of 90%. Kamada's primary competitors are Grifols, CSL & Takeda.

Website

kamada.com

Frequently Asked Questions about Kamada

  1. When was Kamada founded?

    Kamada was founded in 1990
  2. Who is Kamada's CEO?

    Kamada's CEO is Amir London
  3. How much revenue does Kamada generate?

    Kamada generates $128.4M in revenue
  4. How much funding does Kamada have?

    Kamada has historically raised $25M in funding
  1. Where is Kamada's headquarters?

    Kamada's headquarters is in Rehovot Tel Aviv District, IL
  2. How many employees does Kamada have?

    Kamada has 319 employees
  3. What sector does Kamada operate in?

    Kamada is in Pharmaceuticals
  4. Who are Kamada's competitors?

    Kamada's top competitors are Grifols, CSL, Takeda